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Celebrating Similarities—Embracing Differences
Laurie Goodman1
Cold Spring Harbor Laboratory, Cold Spring Harbor, New York 11724 USA
Using model systems to gain a better
understanding of human disease and
the underlying biology is standard in
biological research. The power of model
systems, however, has never been so
great as in recent years with the growing
availability of a wealth of genomic data
from a variety of animals and plants and
the ever more-advanced tools for prob-
ing, classifying, and characterizing these
resources. There are few better examples
illustrating the usefulness of model sys-
tems as the material presented at the
“Yeast Genetics and Human Disease II”
meeting, which took place 3 months
ago in Vancouver, Canada (June 24–27,
1999). The meeting, which included
talks that covered far more than just
yeast as a model system, was undeniably
successful. Meeting attendees’ primary
complaint, in fact, was the press for
time; poster sessions started at 7:45 a.m.
and talks ended at 10 p.m. This is a rela-
tive standard day for most meetings, ex-
cept for the very early rise. The com-
plaint, however, was due to the fact that
most attendees sat through every single
talk, rather than taking breaks here and
there. A quick dash out into the hallway
for a bathroom break or a coffee refill
showed an empty corridor, rather than
what is usually seen at meetings—a hall-
way containing several clustered groups
talking about previous presentations,
waiting for talks that will come up later
in the day, or discussing current or po-
tential collaborations with colleagues.
The information presented at the
meeting was compelling, though not
necessarily for its newness but, rather,
for the context of the presentations. The
composition of talks and attendees var-
ied widely in terms of system and sub-
topic studied, but the theme in each ses-
sion formed a cohesiveness that enabled
listeners to appreciate the broader per-
spective and to see clearly the power
gained in utilizing information from a
broader spectrum of organisms and
tools. Like the first meeting held 2 years
ago in Baltimore, this conference held
forth the strength of yeast (for the most
part, especially in this report, Saccharo-
myces cerevisiae) as a system to use to un-
derstand human disease; but with 2
years time to look at the first completely
sequenced eukaryotic genome, there
was also an increasing awareness of the
differences.
Sequence and, potentially, func-
tional homology of genes and proteins
are the primary reasons why model sys-
tems are at all useful. That genes, pro-
teins, and biological systems share a
level of similarity in all organisms can
often be taken for granted but just how
much similarity different organisms
share can sometimes be surprising given
their evolutionary distances. Even given
this surprising similarity, differences do
exist, and as such, extrapolation from
one system to another requires caution.
The power in using model systems
comes from being able to define both
the similarities and the differences, and
to use these in an intelligent way to best
direct the research.
Functional similarity has numerous
applications, but the relevance of that
similarity from one organism to another
may be far from complete. Worse, as was
pointed out by Geoff Duyk, when con-
sidering a particular model organism’s
overall relevance to humans, the ease in
which that organism can be worked
with in the laboratory is generally in-
versely proportionate to its relevance.
But this is overall relevance. Growing un-
derstanding of functional similarity
and/or homology and the use of this as a
tool to direct research in a pinpointed
fashion can help one pick and choose
when to utilize a system that allows ease
at getting at specific aspects of a biologi-
cal pathway and when a whole organ-
ism approach is required to better un-
derstand the implications of a genetic
change on the organism as a whole, and
how that might relate to humans.
As previously indicated, the presen-
tations at the Vancouver meeting were
classified by their area in biology, for ex-
ample, cell cycle, RNA metabolism and
translation, chromosome and genome
stability, and so on. But there were other
ways to classify these talks, ways that
transcended their biological classifica-
tions—making each talk useful from a
conceptual standpoint to anyone, no
matter their “biological sect.” Experi-
ments from any biological discipline
could really fall into three categories:
use of a model system to define a disease
gene (or unknown gene) function; use of
a model system to dissect cellular
mechanisms; and use of large data sets
to classify and characterize novel genes
in known biological systems, pathways,
or components.
Given yeast, with its complete ge-
nome, in conjunction with the plethora
of other model organisms, some also
with complete genomes (Caenorhabditis
elegans and numerous bacteria and ar-
chaea), as well as growing sequence data
for mouse, human, Drosophila, Arabidop-
sis, and so on, current advances are and
should continue to cross species and dis-
ciplinary boundaries, as this can only in-
crease our understanding of general bio-
logical systems and our own place
within these.
Gene and Protein Homology
Gavin Sherlock (Stanford University)
and Eugene Koonin (National Institutes
of Health) provided meeting attendees
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with the greatest overview for what is
found when identifying sequence ho-
mology when comparing genomes. Sher-
lock focused on an analysis of the com-
plete yeast genome compared with last
year’s completed C. elegans genome se-
quence (Chervitz et al. 1998), whereas
Koonin presented a series of comparative
studies from a variety of organisms (many
still with incomplete genomes), providing
examples of sequence homology from
particular gene families and protein do-
main studies, such as nucleotidyltransfer-
ases (Aravind and Koonin 1999) or BRCT
domains (identified originally in BRCA)
(Bork et al. 1997) present in bacteria,
yeast, C. elegans, and humans. The main
message from both talks was that while
complete proteins themselves are not nec-
essarily conserved (and in most cases, un-
likely to be conserved), functional do-
mains persist over evolution. A domain,
as defined by Koonin, must fulfill three
criteria: (1) It should be statistically sig-
nificant, that is there is a low expectation
that the domain would occur by chance
alone; (2) it should have a level of indi-
viduality; a presence in different contexts
in different proteins; and (3) it should
have an evolutionary resilience of the
conserved features and a correlation of
these features with structural and func-
tional cognates. Both Koonin and Sher-
lock showed that while functional do-
mains are conserved, the number and
overall architecture of proteins from one
species to another is not conserved. Gen-
erally, as the complexity of an organism
increases, the complexity (in terms of
number and position of functionally con-
served domains) and the overall number
of increasingly complex proteins increase.
Work now proceeds to define as many
functional domains as possible to gener-
ate a complete list of all these domains in
every organism. Clearly, such a catalog
would be invaluable; a point made infi-
nitely apparent in other talks at the meet-
ing, where studies relied heavily on both
the use and understanding of gene homo-
logues of different organisms in order to
answer biological questions.
Defining Disease Gene Function
The identification of human disease
genes continues to become more
straightforward as more sequence data,
higher quality maps, and better re-
sources and tools become available. But
the identification of the gene is really
only the starting point for understand-
ing the cause of a disease. Obviously
studying blindness or brain disease in
organisms such as yeast or C. elegans
may seem to lack the main components
for getting at such diseases—the pres-
ence of eyes or brains. Comparative
studies, however, provide one of the
greatest tools for getting at the mecha-
nisms underlying disease at the cellular
level. Although such studies are unlikely
to give the whole story, they can provide
vital clues for where to search in under-
standing the role of the human homo-
log.
Several nice examples of these types
of studies were presented at the Vancou-
ver meeting. One presentation was the
analysis of the yeast Batten disease gene
homolog. Batten disease is a recessive,
progressive neurodegenerative disorder,
commonly associated with blindness,
loss of mental abilities, motor skills, in-
creasing number and severity of sei-
zures, and, finally, premature death.
One of the cellular features of the dis-
ease is an accumulation of material in
the lysosomes. The gene underlying this
disorder, CLN3, was identified in 1995
by The International Batten Disease
Consortium. Analysis of the gene indi-
cated that it was completely novel and
not much more beyond that. Moving to
yeast, David Pearce and colleagues (Uni-
versity of Rochester) identified a CLN3
yeast homolog, BTN1, and determined
that its gene product is located in the
yeast vacuole. Then, using microarray
analysis to compare the expression of all
yeast genes in BTN1 and btn1 yeast cells,
the researchers found a change in ex-
pression of two genes: HSP30 expression
decreased and BIN2 expression in-
creased in bin1. Of interest, HSP30 ex-
pression was known to increase in re-
sponse to increased plasma membrane
ATPase activity when vacuolar mem-
brane pH regulation is altered. Based on
these findings, Pearce and colleagues
propose that Batten disease may be
caused by a defect in vacuolar (or in hu-
mans, lysomosal) pH control. (Pearce et
al. 1999; Pearce and Sherman 1999). Fo-
cus should move to investigate the po-
tential role pH may play in Batten dis-
ease cells.
In a similar type of study, Carla
Koehler (University of Basel) analyzed
yeast homologs to gain a better under-
standing of the cellular mechanisms un-
derlying Mohr-Tranebjaerg syndrome,
which is a human deafness dystonia.
The disease is caused by a defect in an-
other gene of unknown function, DDP1
(Tranebjaerg et al 1995; Jin et al. 1996).
DDP1 is on the X chromosome. The dis-
ease, however, does have some similari-
ties to mitochondrial disorders, as it es-
pecially affects nerve and muscle tissues.
Koehler and colleagues, investigating
protein import into mitochondria, iden-
tified several small proteins (Tim8,
Tim9, Tim10, Tim12, and Tim13) that are
similar to DDP1 (it had greatest similarity
to Tim8). They also found that DDP1 is a
mitochondrial protein. Tim8 appears to
mediate the import of a particular subset
of proteins into the mitochondria
(Koehler et al. 1999). Further studies on
the activity of Tim8 and on DDP1 should
aid in elucidating the exact biochemical
role the protein plays in the cell.
Both of these examples, along with
many more at the meeting, provide a
clear indication of the way in which
work with yeast homologs can provide
useful clues for determining the func-
tion of a disease gene. Obvious care
must always be taken as to how far the
similarity in function might extend. Re-
call that while studies do indicate a con-
servation of functional domains, with
domain swapping and the creation of
new and more complex proteins, pur-
ported homologs may share some of the
basic biochemical activities; but
whether this similarity extends to any
biological relevance remains suspect. It
is vital to consider additional points,
such as the extent of the similarity be-
tween protein domain architecture, par-
allels in cellular location, and even pro-
tein-protein interactions of your protein
of interest and those of its homolog. Ho-
mology studies can give important
clues, but these must be used in a bio-
logical and evolutionary context.
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Dissecting Cellular Mechanisms
Given a high similarity of function be-
tween two genes or proteins of different
organisms, the organism that is simpler
to work with is the system of choice for
studying details of cellular mechanisms.
Several talks demonstrated the strength
of the yeast system, both from a genetic
and a biochemical standpoint for look-
ing at the details of a variety of cellular
mechanisms. Both Reed Wickner (The
National Institutes of Health) and Sue
Lindquist (University of Chicago)
(Lindquist et al. 1998; Zhou et al. 1999)
presented data on their studies of prion-
like proteins in yeast. While it is (hope-
fully) unlikely that newspapers will sud-
denly begin crying “Mad Yeast Disease,”
producing a rabid public concern about
the dangers in eating bread, there are
several yeast genes that produce protein
products with prion-like behavior, mak-
ing this a potentially terrific system to
study prions.
There are a number of yeast genes
that produce a normal form of their pro-
tein, but also an altered form that aggre-
gates, and can aggregate their normal
counterparts. Wickner presented data
on [URE3], the prion form of the URA2
gene (Edskes et al. 1999, Maddelein and
Wickner 1999, Taylor et al. 1999), and
Lindquist presented data on [PSI], the
prion form of the SUP35 gene. Both
Wickner and Lindquist presented data
from systems they had developed to ex-
press particular domains of the proteins,
which allowed them to define which re-
gions of the protein were required or suf-
ficient for prion activity. Given these
data, Wickner pointed out that the yeast
system could be used as a sort of prion
“Ames test,” allowing researchers to
look for prion-inducing and curing
agents. Yeast could also be used for mo-
lecular screening for protein domains
that are able to produce infectious pro-
teins.
What might be considered standard
cellular activity can also be easily stud-
ied in yeast and applied to other organ-
isms from a mechanistic standpoint. For
example, Diane Cox (University of Al-
berta) and Jonathan Gitlin presented de-
tails of the use of yeast for studying cop-
per transport and homeostasis in yeast.
As a model, the data provided informa-
tion on how copper transport affected
its utilization in humans and the poten-
tial roles in disease by human homologs
(Forbes et al. 1999, Suzuki and Gitlin
1999). Other cellular activities, such as
replication and the mechanisms in-
volved have a long history of being well-
served by initial analyses in yeast. Doug
Koshland (Carnegie Institute of Wash-
ington) presented data on sister chroma-
tid cohesision that continue to high-
light the strength of the yeast system. In
the work by Koshland and colleagues,
the yeast two-hybrid system helped de-
termine some of the proteins that bind
to centromeres and cohesion sites. They
were also able to map the region within
the yeast centromere that these proteins
bind and to investigate the sequences re-
quired for such binding. The data indi-
cated that the centromeric region is re-
quired to load these proteins and that
they spread from there. This “loading re-
gion” is also required to keep these pro-
teins on the sister chromatids during
cell division (Megee and Koshland
1999).
Large-Scale Identification
of Novel Genes
While yeast has been and clearly contin-
ues to be useful for helping to decipher
unknown gene function and to more
easily study cellular mechanisms, the
now complete sequence of the yeast ge-
nome allows researchers to apply new
tools to better understand the function
of genes and gene families in a large-
scale fashion. The primary focus at the
meeting for classifying gene function in
large-scale studies included, for ex-
ample, studies based on gene expres-
sion, in which the complete array of
yeast genes were analyzed using DNA ar-
ray technology, and the expression pat-
terns were examined and characterized.
Bruce Futcher (Cold Spring Harbor Labo-
ratory) presented data from which he
and his colleagues looked for genes
whose expression varied with cell cycle,
providing a set of ~ 700 genes that are
likely to be involved in the cell cycle
(Spellman et al. 1998). In addition to
gene expression analysis, Eric Phizicky
(University of Rochester) presented a
method to identify genes based on the
activity of their proteins. Phizicky and
colleagues expressed all the yeast genes
as tagged proteins and then assayed
these tagged proteins for particular bio-
chemical activities. The genes for these
proteins, once linked with some known
biochemical function, can be identified
and analyzed further, and their genes
classified based on these biochemical
functions. In a similar fashion, proteins
(and the genes encoding them) can be
identified based on broader biological
bases. James Broach (University of Prince-
ton), for example, presented a method
whereby yeast could be used as a system
to pull out unknown human G-protein-
coupled receptors (Klein et al. 1998). In
this last example, once again due to
similarity of cellular systems from one
organism to the next, yeast can be used
as a tool in which to analyze proteins
from other organisms.
The use of expression data for clas-
sifying and characterizing large numbers
of genes was a main theme at the meet-
ing. The usefulness of such analyses for
tackling the large data sets that come
from completely sequenced genomes is
undeniable, as these classifications pro-
vide the first clues as to what all of these
genes are doing and how they work to-
gether to maintain all cellular functions
in all environments. Equally clear is that
a public database that allows researchers
to dip into such expression (or bio-
chemical activity) databases would be
an incredibly useful tool for the commu-
nity. It would allow new data by anyone
to be compared and contrasted with
data already accumulated and stored. As
an example, Douglas Bassett and Mat-
thew Marton (both at Rosetta Inphar-
matics) presented information on Roset-
ta’s private expression database (Marton
et al. 1998). Their database stores and
allows the comparison and analysis of
thousands of yeast gene-expression pro-
files from DNA microarray experiments.
The data appeared to provide quite pow-
erful and useful comparisons of changes
in gene expression from different ge-
netic perturbations, drug treatments, re-
sponses to different growth conditions,
Insight/Outlook
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and so on, allowing researchers using
the database to make connections be-
tween, for example, genetic alterations
and environmental changes, or as an aid
to drug target selection or even drug se-
lection for different genotypes. Seeing
these studies, and recognizing the power
in many of the other expression studies
presented at the meeting, the develop-
ment of a public expression database
will certainly be as useful as current gene
and protein sequence databases are for
classifying genetic unknowns based on
sequence similarity.
Conclusions
All in all, with all the advances being
made, there is still a long way to go.
More genomes await their completion—
although there is growing excitement
about the Drosophila genome sequence
to be released this month from Celera in
collaboration with researchers at The
University of California, Berkley; the
completion of the Arabidopsis genome
next year; and increasing prospects from
the expeditious work on the human and
mouse genomes. These soon-to-come
completely sequenced genomes cer-
tainly raise our anticipation about what
we will be able to discover about our-
selves and the world around us, but be-
fore we can begin with our future, there
remains a great deal more to do with se-
quence in hand.
“In yeast, we have had the whole
genome complete for 2 years now, and
we don’t know where transcripts start,
or even the definition of a gene. As a
community, we really need to focus on
this,” Ira Herskowitz pointed out at the
meeting, in consideration of Munira
Basrai’s presentation on the difficult
matter of identifying the often ignored
small ORFs (<100 codons) that are pres-
ent in the yeast genome—ORFs too
small to identify as potential genes
when using current gene-finding com-
puter programs, a problem since some of
these small ORFs clearly have biological
relevance (such as the 36-amino acid a
factor precursor protein).
That said, there remains an equal
amount to celebrate. The collaborative
spirit at the Vancouver meeting, the
high interest the attendees had for seem-
ingly disparate studies, and the ease
with which different disciplines shared
data and ideology indicate an exciting
road ahead with abundant data, new
tools, more ideas, and increasing col-
laborations spanning organisms and dis-
ciplines.
The “Yeast and Human Disease III”
meeting, 2 years hence should, if any-
thing, only be more interesting.
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